The documented changes in blood components during LVAD support are the activation of platelets, changes in platelet receptors [6] and the reduction in large multimers of the von Willebrand factor (vWF) leading to the development of the acquired von Willebrand syndrome (aVWS), which is associated with bleeding [7,8]. The gene discussed is VWF; the disease is acquired von willebrand syndrome.